Table 2.
Liver iron concentration (mg/g dry weight) | Type of study | Deferiprone group |
Deferoxamine group |
p | Reported outcome variable | ||
---|---|---|---|---|---|---|---|
n | Outcome | n | Outcome | ||||
Using liver biopsy | |||||||
Maggio et al. [2002] | Randomized controlled trial | 20 | 1.02 (3.51) | 15 | 0.35 (0.52) | 0.44 | Difference in mean (SD) |
Pennell et al. [2006] | Randomized controlled trial | 29 | 0.93 (2.9) | 32 | 1.54 (2.5) | 0.4 | Difference in mean (SD) |
Normal range 0.35–1.36 mg/g dry weight | |||||||
Using MRI T2* | |||||||
Anderson et al. [2002] | Case control | 15 | 5.1 (2.8–10.0) | 30 | 3.5 (2.7–4.6) | 0.03 | Median (IQR) (mg/g dry weight) |
Perifanis et al. [2007] | Retrospective | 19 | 3.29 (2.5) | 23 | 8.16 (8.4) | 0.014 | Mean (SD) (ms) |
Normal range 0.35–1.36 mg/g dry weight | |||||||
Normal range >6.7 ms |
IQR, interquartile range; MRI, magnetic resonance imaging; SD, standard deviation.